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Abstract
Malignant pleural effusion (MPE) is a common clinical problem of concern for most of the pneumologists and
thoracic surgeons. A general consensus regarding the use of talc poudrage in treatment of MPE exists, but only
few studies analyzed in detail talc insufflation related pulmonary morbidity. In particular, ARDS talc-related is caused
by physical and chemical effects of the small talc particles (50% particle size <15 μm) and its occurrence is
independent from the underlying disease, the quantity of talc used or the technique of talc instillation. In our
series we observed 3 cases only (0.75%) of talc-related lung injury. This data strongly confirm the low rate of talc-
related lung injury after talc poudrage in treatment of MPE regardless the amount of talc insufflated.
Letter to the editor
We read with great interest the report by Barbetakis et
al [1] on morbidity, mortality and life expectancy fol-
lowing thoracoscopic talc insufflation. Malignant
pleural effusion (MPE) is a common clinical problem
of concern for most of the pneumologists and thoracic
surgeons. In the US the annual incidence of MPE is
estimated to be 250.000 cases and several studies sug-
gest that exudative effusions are by large (42 - 77%)
caused by malignancy [2]. A general consensus regard-
i n gt h eu s eo ft a l cp o u d r a g ei nt r e a t m e n to fM P E
exists, only few studies analyzed in detail talc insuffla-
tion related pulmonary morbidity. The most common
side effects are pleuritic chest pain and mild fever.
However very serious and potentially fatal adverse
events, albeit unusual (1 to 9% in published series [3]),
as such as an adult respiratory distress syndrome
(ARDS), can happen and these are related to the physi-
cal and chemical effects of the small talc particles (50%
particle size <15 μm).
The occurrence of ARDS is, in fact, independent from
the underlying disease, the quantity of talc used or the
technique of talc instillation but it’s strongly related to
talc particle size. A greater alveolarearterial oxygen gra-
dient in the group exposed to non-graded talc at 48 h
after pleurodesis was detected when matched with that
of those exposed to graded talc [4].
In our department, in the period between 01/95 and
10/10, we performed thoracoscopic talc pleurodesis in
401 patients with MPE. As previously reported in our
data [5], we performed a “single access” technique in
those cases with no evidence of pleural adhesions or
loculated effusions (241 patients), while 160 patients
underwent a standard thoracoscopy. We routinely used
an average of 4 grams (range 2-28 grams) of large-
particle asbestos-free talc pneumatically atomized
through a soft silicone tube. To be specified that the
u p p e rr a n g e( u pt o2 8g r a m s )w a sr e a c h e di nt h o s e
cases (15 patients) with high (up to 500 ml/die) flow. In
our series we observed 3 cases only (0.75%) of talc-
related lung injury (acute respiratory failure in 2 cases
and acute pulmonary edema in 1 patient). Our compli-
cation rate is lower to that reported in [1] (acute
respiratory failure in 7 cases and reexpansion pulmonary
edema in 1 patient), although the Authors have denied a
correlation between talc insufflation and pulmonary
complications. As well, differently from the evidence
reported by Montes et al [6], we did not observe any
complications in the 15 cases insufflated with more than
8 grams of talc.
Our results confirm the low rate of talc-related lung
injury after talc poudrage in treatment of MPE regard-
less the amount of talc insufflated. We would really
appreciate the Authors’ reflection and reaction in
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graded-talc pleurodesis.
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